TATA Health (01255) issued an announcement that will further delay publication of the 2023 annual results. The reason is that on the date of this announcement, the company was still collecting and checking the necessary information and documents of its subsidiaries in accordance with the auditor's requirements to complete the review process, so the company needed additional time to prepare the 2023 annual results. The company is in close communication with its subsidiaries and auditors to gather all necessary information and documents to complete the audit process as soon as possible. However, the expected publication date of the 2023 annual results will require further discussion and determination with the auditors, and an announcement will be issued in due course.
Trading of the company's shares continues to be suspended.